This study found no significant differences in the relative quantification of PRPF31 mRNA expression levels between RP11 patients and NPC, suggesting that PRPF31 mRNA expression may vary across different tissues and that whole blood is not an optimal medium for monitoring PRPF31 mRNA expression [64]. The gene discussed is PRPF31; the disease is nasopharyngeal carcinoma.